• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阶梯式治疗对心肌梗死和心绞痛发病率的影响。高血压检测与随访项目的5年研究结果。

Effect of stepped care treatment on the incidence of myocardial infarction and angina pectoris. 5-Year findings of the hypertension detection and follow-up program.

出版信息

Hypertension. 1984 Mar-Apr;6(2 Pt 2):I198-206. doi: 10.1161/01.hyp.6.2_pt_2.i198.

DOI:10.1161/01.hyp.6.2_pt_2.i198
PMID:6724670
Abstract

Information on indices of coronary heart disease (CHD) and myocardial infarction (MI) (angina pectoris by Rose Questionnaire, MI by Rose Questionnaire, history, and electrocardiogram) was obtained in the Hypertension Detection and Follow-Up Program (U.S. National Institutes of Health) at baseline, Year 2, and Year 5 of follow-up. The presence of any of these findings at baseline markedly increased all-cause mortality during the 5 years of observation. In individuals with negative findings at baseline, the 5-year incidence of MI and angina pectoris by these indices was less in the Stepped Care than Referred Care cohort. These results are compatible with the conclusion that antihypertensive therapy reduces the incidence of symptomatic CHD.

摘要

在高血压检测与随访项目(美国国立卫生研究院)中,于随访的基线期、第2年和第5年获取了冠心病(CHD)和心肌梗死(MI)的相关指标信息(通过罗斯问卷评估心绞痛、通过罗斯问卷评估心肌梗死、病史以及心电图)。基线期出现这些发现中的任何一项,都会显著增加5年观察期内的全因死亡率。在基线期检查结果为阴性的个体中,与转诊护理队列相比,阶梯式护理队列中通过这些指标得出的MI和心绞痛的5年发病率更低。这些结果与抗高血压治疗可降低有症状CHD发病率的结论相符。

相似文献

1
Effect of stepped care treatment on the incidence of myocardial infarction and angina pectoris. 5-Year findings of the hypertension detection and follow-up program.阶梯式治疗对心肌梗死和心绞痛发病率的影响。高血压检测与随访项目的5年研究结果。
Hypertension. 1984 Mar-Apr;6(2 Pt 2):I198-206. doi: 10.1161/01.hyp.6.2_pt_2.i198.
2
Black-white comparison of indices of coronary heart disease and myocardial infarction in the stepped-care cohort of the Hypertension Detection and Follow-Up Program.高血压检测与随访项目阶梯式照护队列中冠心病和心肌梗死指标的黑白人种比较。
Am Heart J. 1984 Sep;108(3 Pt 2):797-801. doi: 10.1016/0002-8703(84)90674-4.
3
Cardiovascular risk factors for stable angina pectoris versus unheralded myocardial infarction.稳定型心绞痛与隐匿性心肌梗死的心血管危险因素
Am Heart J. 2004 Mar;147(3):502-8. doi: 10.1016/j.ahj.2003.09.010.
4
Angina pectoris by Rose questionnaire does not predict cardiovascular disease in treated hypertensive patients.采用罗斯问卷评估的心绞痛不能预测接受治疗的高血压患者的心血管疾病。
J Hypertens. 1995 Nov;13(11):1307-12. doi: 10.1097/00004872-199511000-00013.
5
Unrecognized myocardial infarction: epidemiology, clinical characteristics, and the prognostic role of angina pectoris. The Reykjavik Study.未识别的心肌梗死:流行病学、临床特征及心绞痛的预后作用。雷克雅未克研究。
Ann Intern Med. 1995 Jan 15;122(2):96-102. doi: 10.7326/0003-4819-122-2-199501150-00003.
6
[Therapeutic use of lowering blood pressure, especially in mild hypertension. Results of a hypertension detection and treatment program].[降压治疗的应用,尤其适用于轻度高血压。一项高血压检测与治疗项目的结果]
Z Gesamte Inn Med. 1986 Jun 15;41(12):333-40.
7
Further analyses of the hypertension detection and follow-up program.高血压检测与随访项目的进一步分析
Drugs. 1986;31 Suppl 1:23-8. doi: 10.2165/00003495-198600311-00006.
8
Predictors of angina pectoris versus myocardial infarction from the Women's Health Initiative Observational Study.来自女性健康倡议观察性研究的心绞痛与心肌梗死的预测因素。
Am J Cardiol. 2004 Mar 15;93(6):673-8. doi: 10.1016/j.amjcard.2003.12.002.
9
Epidemiologic assessment of angina before and after myocardial infarction: The Framingham study.心肌梗死前后心绞痛的流行病学评估:弗雷明汉姆研究
Am Heart J. 1996 Jul;132(1 Pt 1):174-8. doi: 10.1016/s0002-8703(96)90406-8.
10
Risk factors of recurrent angina pectoris and of non-fatal myocardial infarction after coronary artery bypass surgery.冠状动脉搭桥术后复发性心绞痛和非致命性心肌梗死的危险因素。
Eur J Cardiothorac Surg. 1996;10(3):173-8. doi: 10.1016/s1010-7940(96)80293-4.

引用本文的文献

1
Pharmacotherapy for hypertension in adults 60 years or older.60岁及以上成年人高血压的药物治疗
Cochrane Database Syst Rev. 2019 Jun 5;6(6):CD000028. doi: 10.1002/14651858.CD000028.pub3.
2
First-line drugs for hypertension.高血压一线用药。
Cochrane Database Syst Rev. 2018 Apr 18;4(4):CD001841. doi: 10.1002/14651858.CD001841.pub3.
3
Antihypertensive pharmacotherapy for prevention of sudden cardiac death in hypertensive individuals.高血压患者预防心源性猝死的降压药物治疗
Cochrane Database Syst Rev. 2016 Mar 10;3(3):CD011745. doi: 10.1002/14651858.CD011745.pub2.
4
Pharmacotherapy for mild hypertension.轻度高血压的药物治疗。
Cochrane Database Syst Rev. 2012 Aug 15;2012(8):CD006742. doi: 10.1002/14651858.CD006742.pub2.
5
Methods underpinning national clinical guidelines for hypertension: describing the evidence shortfall.国家高血压临床指南的支撑方法:描述证据不足情况
BMC Health Serv Res. 2006 Apr 5;6:47. doi: 10.1186/1472-6963-6-47.
6
Interventions for improving adherence to treatment in patients with high blood pressure in ambulatory settings.改善门诊环境中高血压患者治疗依从性的干预措施。
Cochrane Database Syst Rev. 2004;2004(2):CD004804. doi: 10.1002/14651858.CD004804.
7
Hypertension registry as the base for population health care.
J Med Syst. 1996 Apr;20(2):111-28. doi: 10.1007/BF02260895.
8
The relative risk of myocardial infarction in patients who have high blood pressure and non-cardiac pain.患有高血压和非心源性疼痛的患者发生心肌梗死的相对风险。
J Gen Intern Med. 1987 Nov-Dec;2(6):381-7. doi: 10.1007/BF02596362.
9
The effects of antihypertensive drugs on serum lipids and lipoproteins, I. Diuretics.抗高血压药物对血脂和脂蛋白的影响,I. 利尿剂。
Drugs. 1986 Sep;32(3):260-78. doi: 10.2165/00003495-198632030-00003.
10
Further analyses of the hypertension detection and follow-up program.高血压检测与随访项目的进一步分析
Drugs. 1986;31 Suppl 1:23-8. doi: 10.2165/00003495-198600311-00006.